Published: 7 March 2017
Author(s): Gala Gutierrez-Buey, Jorge M. Núñez-Córdoba, María Llavero-Valero, Javier Gargallo, Javier Salvador, Javier Escalada
Issue: March 2017
Section: Original Article

Non-alcoholic fatty liver disease (NAFLD) is the commonest hepatic disease in many parts of the World, with particularly high prevalence in patients with type 2 diabetes (T2DM). However, a good screening test for NAFLD in T2DM has not been established. Insulin resistance (IR) has been associated with NAFLD, and homeostatic model assessment of insulin resistance (HOMA-IR), a good proxy for IR, may represent an affordable predictive test which could be easily applied in routine clinical practice. We aimed to evaluate the diagnostic accuracy of HOMA-IR for NAFLD in T2DM and sought to estimate an optimal cut-off value for discriminating NAFLD from non-NAFLD cases.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.